论文信息 - Problems, challenges, and initiatives in translation - 字舞流文

Problems, challenges, and initiatives in translation

Abstract The potential but also limitations of the translational approach are discussed, as are the current initiatives and challenges of the still evolving subject. Numbers and reasons for attrition are provided.

[1] B. Parsons,et al. Personalized cancer treatment and the myth of KRAS wild-type colon tumors. , 2013, Discovery medicine.

[2] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[3] N. Dahiya,et al. The Evolving Drug Development Landscape: From Blockbusters to Niche Busters in the Orphan Drug Space , 2014, Drug development research.

[4] Michael Levitt,et al. Future of fundamental discovery in US biomedical research , 2017, Proceedings of the National Academy of Sciences.

[5] R. M. Owen,et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies , 2015, Nature Reviews Drug Discovery.

[6] Mark R. Trusheim,et al. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers , 2007, Nature Reviews Drug Discovery.